about
Silicone gel sheeting for preventing and treating hypertrophic and keloid scarsHypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies5-Fluorouracil in the Treatment of Keloids and Hypertrophic Scars: A Comprehensive Review of the LiteratureThe Burn Wound MicroenvironmentEmerging Therapies for Scar PreventionEar keloids: a review and update of treatment optionsCurative effects of oleanolic Acid on formed hypertrophic scars in the rabbit ear modelTherapeutic effects of liposome-enveloped Ligusticum chuanxiong essential oil on hypertrophic scars in the rabbit ear modelNonsteroidal anti-inflammatory drugs for wounds: pain relief or excessive scar formation?Therapeutic improvement of scarring: mechanisms of scarless and scar-forming healing and approaches to the discovery of new treatmentsPulsed dye laser treatment with different onset times for new surgical scars: a single-blind randomized controlled trial.Management of keloids and hypertrophic scars: current and emerging options.Angiotensin II stimulates canonical TGF-β signaling pathway through angiotensin type 1 receptor to induce granulation tissue contraction.Computational Identification of Mechanistic Factors That Determine the Timing and Intensity of the Inflammatory Response.Comparison of the effect of W-shaped and linear skin incisions on scar visibility in bilateral external dacryocystorhinostomy.Severe burn injuries: acute and long-term treatment.Topical Silicone Sheet Application in the Treatment of Hypertrophic Scars and Keloids.Avotermin for the improvement of scar appearance: a new pharmaceutical in a new therapeutic area.Recent advances in dermal wound healing: biomedical device approaches.Assessing quality of healing in skin: review of available methods and devices.Triggering of p38 MAPK and JNK signaling is important for oleanolic acid-induced apoptosis via the mitochondrial death pathway in hypertrophic scar fibroblasts.Fractionated Er:YAG laser versus fully ablative Er:YAG laser for scar revision: Results of a split scar, double blinded, prospective trial.Exacerbated and prolonged inflammation impairs wound healing and increases scarring.Angiopoietin-like 4 induces a β-catenin-mediated upregulation of ID3 in fibroblasts to reduce scar collagen expression.Therapies with emerging evidence of efficacy: avotermin for the improvement of scarring.Awake serial intralesional steroid injections without surgery as a novel targeted treatment for idiopathic subglottic stenosis.The long-term follow-up results of external dacryocystorhinostomy skin incision scar with "W incision".Correction of Rhytides, Peau d'Orange, and Thin Dermis of the Face by Neocollagenesis Using Novel Collagen Stimulating Slurry Protocol.Co-delivery of dexamethasone and green tea polyphenols using electrospun ultrafine fibers for effective treatment of keloid.Roles of Macrophage Subtypes in Bowel Anastomotic Healing and Anastomotic Leakage.Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids.
P2860
Q24198088-70D9F5D2-394B-4611-BBE7-090A519791BFQ24595036-9812DCC3-5158-4E58-9CF0-3FC68B8032CAQ26750902-6ED3AD23-129F-472B-94E3-63B3435325DBQ26753839-D3659E8F-240F-4C05-852A-57C45CB34D89Q26778777-C568B854-0304-49B1-9F75-98BA2CF89E54Q26827377-06C97D1D-27D5-4A31-B2C2-25D0C7A0465EQ28709996-41C1E7CD-5B5A-4834-8D3F-D2467B5CE6DBQ28731898-23B06E69-91D1-418C-B8E5-199B2F623B28Q34021948-7344F62D-FE57-446E-96AC-27FE4E001EF0Q34089270-A14D5928-D138-4FD8-A9F2-B99A3E7626EFQ34121563-C25F92F4-B491-41B9-B31D-8C2FC14E32C6Q34699606-E7BFEC49-BDE2-4FA5-B7A3-E6F63988E0F8Q35102380-C7763C6A-DBB7-4B56-8A95-A5BD4E621F12Q35859983-E5C14438-EDF7-401A-957F-B010AA0D49D0Q36347593-18287EA3-E94A-4D5C-95BD-1DF18B3DBEA8Q37405129-110F5FFA-A4A3-4E28-B0CB-82FF6A2DEDC2Q37407460-BAE0FDD3-FB43-48CF-A4FD-634938A27FC1Q37551928-38D5EAB5-8887-40DE-8274-F8B6C76B568BQ37658830-22FE70C0-6E60-40EC-992E-0DE0399E0AF8Q38210586-FC3F300A-76D6-4CA6-820B-836CA35DA98EQ39007133-98E24073-7783-497C-BB44-A0E6B48087C7Q39593117-6A458CBD-2FA5-4E59-A351-1F22AC2D1C51Q40327548-EE4E69BD-2BE4-423E-898B-11FF49C9080FQ41108477-6314FEE1-70E8-40C2-B8E8-D743FB6A59A4Q42460729-5DF90408-2768-4813-9CC3-652F56829158Q46159150-B3CEBB5E-83FC-4D11-9F2A-4B05BEDE39A0Q46485377-0B6724B6-BC92-4CA1-9054-04DCF0A4D272Q46969537-F9E272D1-F249-4ACB-8A0F-5B8AF2ACB56AQ50464347-FE72009D-D001-4279-A285-CBA9B0E545D0Q53175949-0C5A5FCE-E9AF-481A-A977-8EEC3E362E40Q54967102-18892476-7378-4155-9FE0-C27F406F648C
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Scar treatments: preclinical and clinical studies.
@ast
Scar treatments: preclinical and clinical studies.
@en
Scar treatments: preclinical and clinical studies.
@nl
type
label
Scar treatments: preclinical and clinical studies.
@ast
Scar treatments: preclinical and clinical studies.
@en
Scar treatments: preclinical and clinical studies.
@nl
prefLabel
Scar treatments: preclinical and clinical studies.
@ast
Scar treatments: preclinical and clinical studies.
@en
Scar treatments: preclinical and clinical studies.
@nl
P1476
Scar treatments: preclinical and clinical studies.
@en
P2093
Elof Eriksson
Richard G Reish
P304
P356
10.1016/J.JAMCOLLSURG.2007.11.022
P577
2008-01-28T00:00:00Z